tradingkey.logo
搜尋

Drugs Made In America Acquisition Corp

DMAA
添加自選
10.710USD
0.0000.00%
收盤 07-31 16:00美東報價延遲15分鐘
260.01M總市值
74.30本益比TTM

Drugs Made In America Acquisition Corp

10.710
0.0000.00%

關於 Drugs Made In America Acquisition Corp 公司

Drugs Made In America Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The Company intends to focus its search for businesses in the pharmaceutical industry. The Company has neither engaged in any operations nor generated any revenues.

Drugs Made In America Acquisition Corp簡介

公司代碼DMAA
公司名稱Drugs Made In America Acquisition Corp
上市日期Jan 28, 2025
CEOStockwell (Lynn)
員工數量- -
證券類型Ordinary Share
年結日Jan 28
公司地址1 East Broward Boulevard
城市FT LAUDERDALE
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編33301
電話19548703099
網址
公司代碼DMAA
上市日期Jan 28, 2025
CEOStockwell (Lynn)

Drugs Made In America Acquisition Corp公司高管

名稱
名稱/職務
職務
持股
持股變動
Dr. Catherine Do
Dr. Catherine Do
Independent Director Nominee
Independent Director Nominee
100.00K
--
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Saleem Elmasri, CPA
Mr. Saleem Elmasri, CPA
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
名稱
名稱/職務
職務
持股
持股變動
Dr. Catherine Do
Dr. Catherine Do
Independent Director Nominee
Independent Director Nominee
100.00K
--
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Saleem Elmasri, CPA
Mr. Saleem Elmasri, CPA
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--

常見問題

Drugs Made In America Acquisition Corp的前五大股東是誰?

Drugs Made In America Acquisition Corp的前五大股東如下:Dr. Catherine Do

有多少機構持有Drugs Made In America Acquisition Corp(DMAA)的股份?

截至2026Q1,共有54家機構持有Drugs Made In America Acquisition Corp的股份,合計持有的股份價值約為23.26M,占公司總股份的68.99% 。與2025Q4相比,機構持股有所增加,增幅為-2073301.00。
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有